NeoDynamics Investor Relations Material
Latest events
Q1 2024
7 May, 2024
Q4 2023
16 Feb, 2024
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from NeoDynamics
Access all reports
NeoDynamics AB is a Swedish medical technology company focused on advancing cancer diagnosis and treatment. The company's flagship product, NeoNavia, is an innovative biopsy system designed for precise, ultrasound-guided tissue sampling. Built on patented pulse technology, NeoNavia enables controlled needle insertion and accurate placement within tumors, particularly for diagnosing breast cancer and axillary lymph nodes. The company is headquartered in Stockholm, Sweden, and its shares are listed on the Stockholm Stock Exchange.
Latest articles
)
Global Doughmination: Breaking Down Domino's Pizza
Inside the rise of Domino's Pizza: how franchising, delivery control, and supply chain mastery built one of the world's most efficient food empires.
18 Jul 2025
)
The Fifteenth Generation: A Conversation with Pietro Gussalli Beretta
An interview with Pietro Gussalli Beretta on how Beretta Holding blends 500 years of tradition with global growth, innovation, and long-term vision.
10 Jul 2025
)
Citadel: Relentless Optimization at Global Scale
From a Harvard dorm to global dominance, this is the story of how Ken Griffin created one of the best-performing hedge funds of all time.
4 Jul 2025
Ticker symbol
NEOD
Country
🇸🇪 Sweden